substance p has been researched along with Schizophrenia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (53.57) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 2 (7.14) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, K; Hidese, S; Ishida, I; Kunugi, H; Matsuo, J; Yoshida, F | 1 |
| Ballard, TM; Hernandez, MC; Hoffmann, T; Knoflach, F; Malherbe, P; Porter, RH; Schnider, P; Spooren, W; Steward, L; Wettstein, JG | 1 |
| Ishida, T; Kashima, H; Nakajima, S; Suzuki, T; Uchida, H; Watanabe, K | 1 |
| Caberlotto, L; Carletti, R; Corsi, M; Melotto, S | 1 |
| Toru, M | 1 |
| Ichikawa, H; Toru, M | 1 |
| Adachi, S; Kaiya, H; Moriuchi, I; Namba, M; Tamura, Y; Tanaka, M; Yanaihara, C; Yanaihara, N; Yoshida, H | 1 |
| Bouras, C; Constantinidis, J; Richard, J | 1 |
| Shibuya, H | 1 |
| Bacarese-Hamilton, AJ; Crow, TJ; Ferrier, IN; Johnstone, EC; Lee, Y; McGregor, G; O'Shaughnessey, D; Owens, DG; Polak, JM; Roberts, GW | 1 |
| Heikkilä, L; Le Grevés, P; Nyberg, F; Rimón, R; Salmela, L; Terenius, L | 1 |
| Augood, SJ; Emson, PC; Faull, RL; Harrington, KA; McKenna, PJ | 1 |
| Arinami, T; Hamaguchi, H; Itokawa, M; Li, L; Mitsushio, H; Toru, M | 1 |
| Benzer, A; Fischer-Colbrie, R; Fleischhacker, WW; Kirchmair, R; Miller, C; Saria, A; Troger, J; Winkler, H | 1 |
| Aloe, L; Angelucci, F; Fiore, M; Koch, T; Korf, J; Talamini, L | 1 |
| Chahl, LA; Crawter, VC; Tooney, PA | 1 |
| Omenn, GS | 1 |
| Wetterberg, L | 1 |
| Heikkilä, L; Rimón, R; Terenius, L | 1 |
| Iadarola, MJ; Kleinman, JE; Ofri, D | 1 |
| Satoh, K | 1 |
| Bogerts, B; Zech, M | 1 |
| Kalivas, PW | 1 |
| Bracha, HS; Kleinman, JE | 1 |
| Kaiya, H; Morikiyo, M; Ofuji, M; Takeuchi, K; Uematsu, M | 1 |
| Wu, YS | 1 |
| Gillin, CJ; Govoni, S; Hong, J; Iadarola, M; Kleinman, JE | 1 |
9 review(s) available for substance p and Schizophrenia
| Article | Year |
|---|---|
[Brain of patients with chronic schizophrenia and neurotransmitters].
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Chronic Disease; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Humans; Neurotransmitter Agents; Receptors, Dopamine D2; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance P; Tyrosine 3-Monooxygenase | 2005 |
[Neurotransmitters and neuropeptides in schizophrenia].
Topics: Acetylcholine; Brain Chemistry; Endorphins; Enkephalins; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Nerve Tissue Proteins; Neurotransmitter Agents; Norepinephrine; Schizophrenia; Serotonin; Substance P; Vasoactive Intestinal Peptide | 1984 |
Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
Topics: Alzheimer Disease; Brain Mapping; Central Nervous System Diseases; Cholecystokinin; Enkephalins; Humans; Huntington Disease; Limbic System; Nerve Tissue Proteins; Neurotransmitter Agents; Parkinson Disease; Schizophrenia; Substance P; Substance-Related Disorders | 1983 |
[Neuropeptides and mental disorders].
Topics: Aged; Alzheimer Disease; Animals; Brain; Cholecystokinin; Depressive Disorder; Endorphins; Female; Humans; Male; Mental Disorders; Middle Aged; Nerve Tissue Proteins; Neurotransmitter Agents; Schizophrenia; Substance P; Vasopressins | 1983 |
Neurochemistry and behavior in man.
Topics: Affective Symptoms; Behavior; Biogenic Amines; Brain Chemistry; Cyclic AMP; Cyclic GMP; Deficiency Diseases; Humans; Neurochemistry; Neurons; Neurotransmitter Agents; Pain; Peptides; Prostaglandins; Proteins; Receptors, Drug; Schizophrenia; Substance P; Substance-Related Disorders; Synaptic Transmission | 1976 |
[Developing lines in psychoendocrinology].
Topics: Adrenocorticotropic Hormone; Animals; Cortisone; Electroconvulsive Therapy; Endocrine System Diseases; Hormones; Humans; Learning; Memory; Mental Disorders; MSH Release-Inhibiting Hormone; Nerve Tissue Proteins; Peptides; Psychoses, Substance-Induced; Psychotropic Drugs; Schizophrenia; Somatomedins; Somatostatin; Steroids; Substance P; Thyrotropin; Vasopressins | 1977 |
Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon.
Topics: Animals; Behavior, Animal; Cats; Cholecystokinin; Dopamine; Enkephalins; Haplorhini; Humans; Limbic System; Mesencephalon; Nerve Tissue Proteins; Neurokinin A; Neurotensin; Rats; Schizophrenia; Substance P; Swine | 1985 |
Postmortem neurochemistry in schizophrenia.
Topics: Acetylcholine; Brain; Brain Chemistry; Cholecystokinin; Dopamine; Endorphins; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Neurotensin; Neurotransmitter Agents; Norepinephrine; Peptides; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Serotonin; Substance P | 1986 |
Substance P involved in mental disorders.
Topics: Animals; Antipsychotic Agents; Brain; Humans; Mental Disorders; Schizophrenia; Substance P | 1988 |
2 trial(s) available for substance p and Schizophrenia
| Article | Year |
|---|---|
Plasma substance P level in patients with schizophrenia: a cross-sectional study.
Topics: Aged; Antipsychotic Agents; Biomarkers; Cross-Sectional Studies; Dose-Response Relationship, Drug; Humans; Pneumonia, Aspiration; Schizophrenia; Smoking; Substance P | 2011 |
CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin).
Topics: Adult; Biogenic Amines; Chromatography, High Pressure Liquid; Chromogranin A; Chromogranins; Female; Humans; Male; Neuropeptides; Psychiatric Status Rating Scales; Radioimmunoassay; Schizophrenia; Secretogranin II; Substance P | 1996 |
17 other study(ies) available for substance p and Schizophrenia
| Article | Year |
|---|---|
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study.
Topics: alpha-MSH; beta-Endorphin; Bipolar Disorder; Depressive Disorder, Major; Humans; Immunoassay; Neurotensin; Oxytocin; Schizophrenia; Substance P | 2023 |
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.
Topics: Action Potentials; Amides; Aminopyridines; Animals; Antipsychotic Agents; Benzeneacetamides; Dose-Response Relationship, Drug; Female; Gerbillinae; Guinea Pigs; HEK293 Cells; Humans; In Vitro Techniques; Inositol; Ligands; Macaca fascicularis; Male; Mesencephalon; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Phosphorylation; Pyridines; Rats; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Schizophrenia; Substance P; Substantia Nigra | 2011 |
Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Topics: Adult; Aged; Amygdala; Binding Sites; Down-Regulation; Female; Humans; Male; Middle Aged; Mood Disorders; Protein Precursors; RNA, Messenger; Schizophrenia; Substance P; Tachykinins; Tritium | 2005 |
Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Chlorpromazine; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Neurotic Disorders; Psychotic Disorders; Schizophrenia; Substance P | 1981 |
Peptides, the limbic lobe and schizophrenia.
Topics: Brain; Brain Chemistry; Cholecystokinin; Hormones; Humans; Limbic System; Neurotensin; Schizophrenia; Somatostatin; Substance P; Tissue Distribution; Vasoactive Intestinal Peptide | 1983 |
Elevation of substance P-like peptides in the CSF of psychiatric patients.
Topics: Adult; Depressive Disorder; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Peptide Fragments; Peptides; Radioimmunoassay; Schizophrenia; Substance P | 1984 |
Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study.
Topics: Aged; Autoradiography; Caudate Nucleus; Enkephalins; Female; Gene Expression; Humans; In Situ Hybridization; Male; Middle Aged; Oligonucleotide Probes; Organ Specificity; Phosphorus Radioisotopes; Protein Precursors; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2; Reference Values; Schizophrenia; Substance P | 1995 |
An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders.
Topics: Adult; Aged; Alleles; Brain Chemistry; DNA Transposable Elements; Female; Genotype; Humans; Male; Middle Aged; Mood Disorders; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Schizophrenia; Sequence Deletion; Substance P | 1996 |
Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Brain; Disease Models, Animal; Exploratory Behavior; Female; Methylazoxymethanol Acetate; Nerve Growth Factors; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Social Behavior; Substance P | 1999 |
Increased tachykinin NK(1) receptor immunoreactivity in the prefrontal cortex in schizophrenia.
Topics: Adult; Aged; Female; Humans; Immunohistochemistry; Killer Cells, Natural; Male; Middle Aged; Prefrontal Cortex; Schizophrenia; Substance P; Tachykinins | 2001 |
Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Clopenthixol; Dose-Response Relationship, Drug; Drug Administration Schedule; Dynorphins; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Substance P | 1990 |
Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients.
Topics: Adult; Chromatography, High Pressure Liquid; Dynorphins; Enkephalin, Methionine; Female; Humans; Male; Middle Aged; Peptide Fragments; Radioimmunoassay; Schizophrenia; Substance P; Substantia Nigra | 1991 |
Mesocortical neurotensin/dopamine system: is it involved in the pathogenesis of schizophrenia?
Topics: Animals; Brain Mapping; Cerebral Cortex; Dopamine; Enkephalin, Leucine; Frontal Lobe; Growth Hormone; Humans; Macaca; Male; Neurotensin; Schizophrenia; Schizophrenic Psychology; Substance P; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1991 |
Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study.
Topics: Adult; Aged; Basal Ganglia; Enkephalin, Methionine; Female; Humans; Huntington Disease; Immunoenzyme Techniques; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Schizophrenia; Substance P | 1985 |
[The neurochemistry of schizophrenia].
Topics: Adult; Aged; Brain; Choline O-Acetyltransferase; Enkephalin, Methionine; Female; Glutamates; Glutamic Acid; Humans; Male; Middle Aged; Schizophrenia; Substance P; Tyrosine 3-Monooxygenase | 1989 |
[Observations on substance P in the brain and spinal cord in schizophrenia].
Topics: Adolescent; Adult; Brain Chemistry; Humans; Immunohistochemistry; Middle Aged; Schizophrenia; Spinal Cord; Substance P | 1989 |
Neuropeptides in human brain--postmortem studies.
Topics: Adult; Aged; Alcoholism; Brain Chemistry; Cholecystokinin; Enkephalin, Methionine; Heroin Dependence; Humans; Mental Disorders; Middle Aged; Nerve Tissue Proteins; Neurotensin; Psychotic Disorders; Schizophrenia; Substance P; Suicide | 1985 |